Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a report issued on Sunday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

CO opened at $1.01 on Friday. The stock has a market capitalization of $122.77 million, a PE ratio of 1.58 and a beta of 0.16. The stock’s 50 day moving average price is $1.15 and its 200-day moving average price is $1.38. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.